
Eric J Chow MD
Associate Professor, Pediatrics, University of Washington School of Medicine
Join to View Full Profile
825 Eastlake Ave ESeattle, WA 98109
Phone+1 206-520-5000
Fax+1 206-987-3946
Dr. Chow is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of WashingtonFellowship, Pediatric Hematology/Oncology, 2004 - 2007
- University of WashingtonResidency, Pediatrics, 2001 - 2004
- University of California San Francisco School of MedicineClass of 2001
- University of California, Berkeley, School of Public HealthMPH, Epidemiology & Biostatistics
Certifications & Licensure
- ID State Medical License 2022 - 2027
- MT State Medical License 2009 - 2027
- WA State Medical License 2004 - 2027
- AK State Medical License 2021 - 2026
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Selecting Patient-Specific Biologically Targeted Therapy for Pediatric Patients With Refractory Or Recurrent Brain Tumors Start of enrollment: 2013 Dec 01
- Communicating Health Information and Improving Coordination With Primary Care Start of enrollment: 2017 Mar 01
- SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart Start of enrollment: 2018 Aug 31
- Join now to see all
Publications & Presentations
PubMed
- Polygenic risk of coronary artery disease for long-term survivors of breast cancer.Gordon P Watt, Anne S Reiner, Xiang Shu, Kathleen E Malone, Julia A Knight
Journal of the National Cancer Institute. 2025-07-16 - Primary care providers and their needs caring for cancer survivors: a qualitative study.Jean C Yi, Casey A Walsh, Eric J Chow, K Scott Baker, Jason A Mendoza
Journal of Cancer Survivorship. 2025-06-23 - IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer: JACC: CardioOncology Expert Panel.Theodorus W Kouwenberg, Elvira C van Dalen, Renée L Mulder, Saro Armenian, Elizabeth A M Feijen
JACC. Cardiooncology. 2025-06-11
Abstracts/Posters
- Health Care Costs Associated with Contemporary Chronic Myelogenous Leukemia (CML) Therapy Compared to Other Hematologic Malignancies (HEM)Eric J Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Chronic Health Conditions and Late Mortality Among Survivors of Childhood Acute Myeloid Leukemia: A Report from the Childhood Cancer Survivor Study (CCSS)Clinically Re...Eric J Chow, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
- Dexrazoxane Protects the Heart Long Term for Kids Being Treated for CancerMarch 16th, 2023
- Survivors of Childhood Cancer More Likely to Be Undertreated for CVDJune 15th, 2022
- Surviving Childhood Cancer Can Take Toll on Adult HeartJune 8th, 2022
- Join now to see all
Grant Support
- SALSA - Study of Active Lifestyle ActivationFRED HUTCHINSON CANCER CENTER2021–2026
- SALSA - Study of Active Lifestyle ActivationFRED HUTCHINSON CANCER CENTER2021–2026
- Machine Learning-Based Identification of Cardiomyopathy Risk in Childhood Cancer SurvivorsFRED HUTCHINSON CANCER CENTER2023–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: